Paid Clinical Trials Quebec City

Discover 369 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 369

RSV Research in Pregnant Women

Recruiting

PHASE2

Sponsor:

Moderna

Location:

Quebec, Montreal, Ottawa, Halifaxshow 22 more

Code:

NCT06143046

Conditions

Respiratory Syncytial Virus

Eligibility Criteria

Sex: All

Age: 18 - 40

Healthy Volunteers: Accepted

Interventions

mRNA-1345

Placebo

Saruparib

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Quebec, Chicoutimi, Greenfield Park, Montrealshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Single vs. Multiple

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Ste Foy, Montreal, Ottawa, Saint Johnshow 35 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

Transcranial Direct Current Stimulation

Recruiting

Sponsor:

Université de Sherbrooke

Location:

Quebec, Sherbrooke, Montreal

Code:

NCT05617027

Conditions

Pain, Chronic

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

actual transcranial direct current stimulation (tDCS)

placebo transcranial direct current stimulation (tDCS)

Ruxolitinib Cream

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Quebec City, Montreal, Ottawa, Boston MAshow 59 more

Code:

NCT06548360

Conditions

NonSegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib Cream

Vehicle Cream

Sotatercept

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Sainte Foy, Boston MA, Providence RI, Liverpool NYshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Glittre ADL-test

Recruiting

Sponsor:

Laval University

Location:

Quebec City

Code:

NCT03071731

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Bronchodilators

Placebos

Treprostinil

Recruiting

PHASE3

Sponsor:

United Therapeutics

Location:

Quebec, Trois-Rivieres, Boston MA, Liverpool NYshow 85 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

SBRT & Pembrolizumab

Recruiting

PHASE2

Sponsor:

RTOG Foundation, Inc.

Location:

Quebec, Montreal, Boston MA, Lake Success NYshow 15 more

Code:

NCT03546582

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Stereotactic Body Radiation Therapy (SBRT)

Pelvic Health Rehabilitation

Recruiting

Sponsor:

Laval University

Location:

Quebec, Edmonton

Code:

NCT06822582

Conditions

Gynecologic Cancers

Breast Cancer Female

Incontinence

Incontinence Bowel

Sexual Dysfunction

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pelvic Health Module

Upadacitinib vs. Adalimumab

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Sainte-foy, Trois-rivieres, Rimouski, Portland MEshow 75 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo